Diseases Events Announce Your Event Here

No upcoming events

25–27 September 2017 International Conference On Nanomedicine And Nanobiotechnology – ICONAN 2017

Barcelona, Spain

The International Conference On Nanomedicine And Nanobiotechnology is an annual event that hosts high-profile plenary speakers, world-class researchers, oral and poster presentations, workshops, sponsor exhibits and afterworks. It is a great opportunity to share your research findings with a wide audience, promote knowledge exchange, and network. The topics includes:

- Targeted drug delivery and nanocarriers
- Nanomedicine for cancer diagnosis & therapy
- Biological & medical nanodevices and biosensors
- Tissue engineering and regenerative nanomedicine
- Toxicology and risk assessment of nanomedicine systems
- Nano-Imaging for diagnosis, therapy and delivery
- Bionanocatalysis and nanobiosystems
- Microfluidics in nanomedicine and nanobiology

http://premc.org/conferences/iconan-nanomedicine-nanobiotechnology/

10–11 October 2017 The 4th Annual Microbiology & Infectious Diseases Asia Congress

Singapore

Join 300+ delegates and hear 35+ presentations and case studies focusing on the key developments in clinical microbiology, microbial genomics, molecular diagnostics and infectious diseases. Across the 2 days, 4 interactive streams include: Detection Technologies, Molecular Diagnostics and Microbiome Analysis. Clinical Microbiology. Microbial Genomics & Genome Sequencing. Infectious Diseases.

http://www.microbiologyasia-congress.com/

23–24 August 2018 International Conference on Alzheimer's Diseases & Psychology

Paris, France

Scientific Federation is delighted to welcome you to International Conference on Alzheimer's Diseases & Psychology.

The International International Conference on Alzheimer's Diseases & Psychology is anticipating participants from 40 and more countries across the globe and the two day conference will provoke Plenary sessions, Keynote speeches, Poster, and Oral presentations. This program provides two days of robust discussions on recent advancements and new strategies for development of new materials for global requirements.

More information about ICADP-2018 can be found at

http://scientificfederation.com/alzheimers-diseases-psychology-2018/index.php

26–28 September 2018 2nd International Conference on Food Bioactives & Health 2018

Lisbon, Portugal

The FBHC 2018 will take place in the amazing city of Lisbon, from the 26th to the 28th of September, at the Rectory of NOVA University, one of the most prestigious universities in Portugal.

The topics addressed by FBHC2018 will cover the whole palette of interests of the community including the impact of polyphenols, carotenoids, glucosinolates, marine compounds, polysaccharides, peptides and proteins as food bioactives for health. The Conference will strive to afford a delightful forum for the attendees to improve their scientific knowledge and explore the latest trends in the field. It will offer plenty of networking opportunities, providing the opportunity to interact with leading scientists and stimulating creative exchange among researches.

September is a stunning time of the year to visit Lisbon, Europe’s second oldest capital. The city, where the beautiful Tagus river meets the Atlantic ocean, offers a wide variety of tourist attractions to explore: surrounding hills, wonderful well-preserved architecture, magnificent historic monuments, vibrant cultural life, delicious traditional food and great natural sightseeing opportunities.

We hope you will join us for a symphony of outstanding science, and take a little extra time to enjoy the remarkable and exceptional beauty of Lisbon!

More information about FBHC2018 can be found at

http://www.itqb.unl.pt/fbhc2018

11–16 March 2012 Autophagy in Stress, Development & Disease

Ventura, CA, USA

Autophagy is emerging as an important biomedical paradigm with the potential to impact broadly on fundamental biological and translational advances. Autophagy is a homeostatic response of eukaryotic cells to external and internal triggers, allowing them to maintain the quality and quantity of their cytoplasmic components. When properly regulated, autophagy supports normal cellular and developmental processes, whereas autophagic dysfunction is associated with a broad spectrum of human physiological and diseases states. These include aging, musculoskeletal diseases, chronic inflammatory conditions and innate and adaptive immunity, cancer, metabolic disorders, and neurodegenerative diseases such as Alzheimer’s, Huntington’s and Parkinson’s diseases. In parallel with the discoveries related to the fundamental cellular and molecular mechanisms of autophagy, the contributions of this process to the basis of diverse diseases is being uncovered at a rapid pace. The growth in both breath and depth of the field opens new prospects for therapeutic applications. This GRC meeting will capture the latest in molecular, cellular, physiological, and medical advances in the field of autophagy.

http://www.grc.org/programs.aspx?year=2012&program=autophagy

21–24 March 2012 Genomic Disorders 2012: The Genomics of Rare Diseases

Cambridge, UK

This year’s meeting will discuss the latest findings relating to the genomic basis of rare disorders, and the role of rare variants in common disease, as these can provide such powerful insights into human biology. Genome wide analyses, including most recently Whole Exome Sequencing, are proving to be of great value in discovering the genetic basis of rare disorders and illustrate the power of humans as a model organism to study. As sequencing technology advances apace, other key aspects of genome science need to develop and grow in parallel.

https://registration.hinxton.wellcome.ac.uk/display_info.asp?id=273

12–14 April 2012 Valves in the Heart of the Big Apple VII: Evaluation & Management of Valvular Heart Diseases 2012

New York, NY, USA

The goal of this CME activity is to improve patient care by:

  • Reviewing natural histories of patients with common isolated, pure valvular lesions.
  • Discussing and reviewing predictors of outcomes with and without surgery for common valve lesions
  • Presenting and evaluating currently-accepted criteria for surgical intervention.
  • Presenting and evaluating currently approved criteria for use of percutaneously inserted prostheses and/or valve repair techniques
  • Discussing evolving concepts of pharmacological therapy in patients with valvular lesions.
  • Discussing and reviewing current standards for echocardiographic evaluation of valvular diseases, including technical problems and their solutions.

http://www.heartvalveconference.com/

17–20 May 2012 2012 Annual Meeting: Primary Immune Deficiency Disease North American Conference

Chicago, IL, USA

The primary goal of the 2012 Annual Meeting: Primary Immune Deficiency Disease North American Conference is to provide an exciting new venue for the presentation of the newest immune deficiency diseases and the pathogenesis of these defects in molecular terms. The substance of the conference will be cutting edge clinical and basic science research. Another goal is to educate clinicians regarding the state of the art clinical care. We recognize that physicians in training who are likely to see these patients need sessions on the pragmatic aspects of diagnosis and clinical care; thus sessions will be designed to provide a stimulating discussion of these issues, while delving into unsolved questions. The final major goal of this conference is to begin to grow the community of physicians who feel competent to see patients with primary immune deficiency. We believe that this is the only way to consolidate and build up a community of physicians and scientists who are working in this area.

http://www.clinimmsoc.org/meetings/annual-meeting/2012-annual-meeting

23–25 May 2012 The European Conference on Rare Diseases & Orphan Products

Brussels, Belgium

The fact is that while a disease might be labeled as “rare”, the number of persons in Europe suffering from a rare disease is estimated at over 30 million. Rare diseases do not only affect those diagnosed, but their families, friends, care takers and society as a whole. While one rare disease may affect as few as 1 in 50,000 people, rare disease patients collectively comprise 6 to 8 % of the EU population. These statistics do not seem as comforting.

The European Conference on Rare Diseases and Orphan Products is rare. It is the one event where everyone from patients, to policy makers, healthcare professionals, industry, researchers and academics are given the opportunity to meet, exchange information and ideas and join together in the fight against rare diseases. This event provides a unique platform comprising all rare diseases, across all European nations. With over 100 speakers and countless professionals in attendance, this annual conference covers the latest research, developments in new treatments and information regarding innovations in health care, social care and support at both the European and national levels.

ECRD allows you to be on the front lines in the fight against rare diseases, whether you are a patient, family member, healthcare professional, researcher, or simply an interested citizen. The diseases are rare, but the support doesn’t have to be.

http://www.rare-diseases.eu/2012/index.php

9–14 June 2012 7th International Meeting of Microsatellite Instability & Human Disease

Strasbourg, France

The meeting will continue to focus upon the most recent advances in understanding repeat instability of nucleic acids (DNA and RNA) as well as the proteins they affect and their relationship to human diseases. This meeting has a proven track record of rapidly sharing new information, stimulating scientific exchange, collaborations and has served as an excellent venue for training of young scientists (graduate students, post-doctoral fellows and PIs). The multi-disciplinary nature of the research field requires the gathering of clinicians, diagnosticians, pathologists, geneticists and molecular biologists. This is the premier meeting on these mutations and diseases as well as the techniques that are constantly evolving to investigate and potentially treat them. Works presented as podium or poster presentations here have been published in top-tier journals, including Science, Nature, Nature Genetics, Cell, Molecular Cell, Neuron, American Journal of Human Genetics, PLoS Genetics, Human Molecular Genetics, and others.

http://www.microsatellites.ca/2012/index.php

17–21 June 2012 2012 New Directions in Biology and Disease of Skeletal Muscle Conference

New Orleans, LA, USA

The New Directions in Biology and Disease of Skeletal Muscle Conference is returning to New Orleans, Louisiana in 2012. The fifth biennial meeting is being organized by H. Lee Sweeney and Elizabeth McNally. The conference will highlight current developments in muscle biology, disease, and therapy with presentations by leading international researchers.

The previous four meetings brought together muscle researchers who seldom attended the same specialty conferences. Many important scientific relationships and productive collaborations resulted from these interactions.  As in the past, this meeting will provide a unique opportunity for collaborations to develop and thrive while exposing young scientists to a cross section of muscle and neuromuscular disease research.

The meeting format will be highly interactive and will be a combination of platform presentations and poster sessions. Submitted poster abstracts also will be considered for inclusion in relevant discussion sessions.

http://www.acteva.com/booking.cfm?bevaid=225595

15–20 July 2012 Transglutaminases in Human Disease Processes

Davidson, NC, USA

Transglutaminases are a family of structurally and functionally related proteins that are widely distributed in all living organisms. There has been a recent surge in findings supporting that dysregulated expression and function of transglutaminases contribute to pathological conditions, such as cancer metastasis, tissue fibrosis, celiac disease, neurodegenerative disorders, and diseases related to defective assembly of the stratum corneum of the skin. The 2nd Gordon Conference on "Transglutaminases in Human Disease Processes" will focus on this rapidly expanding field. The meeting will cover cutting-edge research on the biology of transglutaminases and their role in health and disease processes. Sessions will cover recent advances relating to the following topics:

  • Transglutaminases in growth, development, and differentiation
  • Transglutaminases as regulators of cell survival and cell death modalities
  • Transglutaminases in cancer development and metastasis processes
  • Transglutaminases and cell signal transduction
  • Transglutaminases in physiological and pathological inflammation
  • Transglutaminases in celiac, neurodegeneration, and cardiovascular disease
  • Transglutaminases-induced matrix remodeling in health and disease
  • Transglutaminases as therapeutic targets
  • Transglutaminases as a tool for biotechnology

http://www.grc.org/programs.aspx?year=2012&program=transgluta

19–22 September 2012 The Genomics of Common Diseases 2012

Potomac, MD, USA

This sixth annual conference marks the 20th anniversary year of the founding of Nature Genetics.  Over the past six years, our understanding of the genetic architecture of disease has been progressively redefined by genome-wide association studies characterizing common variation, the fine mapping of these associated regions, the emergence and growth of new sequencing technologies, and the assessment of rare variant association.

With the improvements in genome sequencing technologies, this past year has seen a rapid increase in the availability of exome and whole genome sequencing datasets. This conference will include presentations highlighting the latest in sequencing technologies with applications to characterize genetic variation and disease associations. The conference will also include presentations on using high-density custom genotyping chips, refining associations through fine mapping, moving from association to function and annotation of functional regions, analyzing sequencing datasets, and exploring the genetic architecture of common disease.

Nature Genetics in association with the Wellcome Trust is pleased to announce the sixth annual Genomics of Common Diseases meeting, which will address the following topics across a range of common diseases:

  • Exome and whole genome sequencing
  • Custom genotyping chips and fine mapping
  • Clinical and targeted sequencing
  • Regulatory and functional genomics
  • Cancer genomics
  • Clinical translation and pharmacogenetics
  • Statistical analyses of sequencing datasets
  • Population and evolutionary genetics
  • Infectious disease and host genetics

http://www.nature.com/natureconferences/gcd2012/index.html

27–30 October 2012 3rd International Conference on Stem Cells and Cancer (ICSCC-2012): Proliferation, Differentiation and Apoptosis

New Delhi, India

The 2nd ICSCC was a grand success in October 2011. It was one of the biggest International gatherings in India in the field of stem cells, molecular medicine and cancer biology. We had excellent invited speakers and presentations in the Oral and Poster presentation categories. The overall objective of advancing the science and bringing people together was met and appreciated by all participants.

This year, we have decided to organize this event in the city of Delhi. It is a great historical city connected by direct flights to most cities in the world. Delhi has many historical & modern monuments and many museums for the art lovers. It has nice weather in October with temperature around 25 degrees Celsius. Many great tourist places like Agra, Jaipur, Shimla, Varanasi, Lucknow etc. are nearby and connected with direct flights or trains from Delhi.

http://www.icscc.in/

21–23 November 2012 The II International Conference on Antimicrobial Research (ICAR2012)

Lisbon, Portugal

The II International Conference on Antimicrobial Research (ICAR2012) will be a forum for the presentation, exchange and dissemination of information and experiences on anti-microbe strategies, in biotic or abiotic environments, in planktonic or adhered states, in biologically specific or unespecific ways, in vitro or in vivo, in a general context marked by the threat posed by the increasing antimicrobial resistance of pathogenic microorganisms. “Anti” is here taken in a wide sense as “against cell cycle, adhesion, or communication”, when harmful for the human health, industry or economy (infectious diseases, chemotherapy, food, biomedicine, agriculture, livestock, biotechnology, water systems...). It will cover topics on antimicrobial resistance, (early) microbial and resistance detection, enhancement of innate defences against pathogens, as well as methods & techniques.

http://www.formatex.org/icar2012/

10–14 December 2012 Pediatric Emergency Medicine: Emergent and Urgent Challenges

Hyatt Regency Sarasota, FL, USA

Following this course, the participant should be able to formulate an appropriate differential diagnosis of the various presenting disorders; apply proper life-stabilizing measures as well as identify the life-threatening emergencies as requiring urgent treatment and/or hospital admission; organize an approach to diagnosis and test ordering and develop a treatment plan based on current evidence as well as providing cost-effective outcomes. This activity is expected to result in improved competence in making an appropriate diagnosis and providing effective treatment and referral or follow-up care with the overall goal of improving patient outcomes.

The emphasis will be on aligning physician behavior with current guidelines and evidence-based medicine, as indicated within each topic’s specific objectives, with a focus on diagnosis, treatment and when to refer. There is a need to improve the competence and practice strategies in the field of Pediatric Emergency Medicine since it affects not only those in EM but even those practicing in clinical settings such as FP, GP and Pediatricians; therefore, this course was designed as an update for all practitioners at the level of a practicing physician.

http://www.ams4cme.com/www/LiveSeminars/SEMLA-2720121210.aspx

13–15 December 2012 2012 Advances in Inflammatory Bowel Diseases, Crohn’s & Colitis Foundation’s Clinical & Research Conference

Hollywood, FL, USA

We are pleased to invite you to the 2012 Advances in Inflammatory Bowel Diseases, Crohn’s & Colitis Foundation’s Clinical & Research Conference. We are excited to celebrate the 11th anniversary of what has become the “can’t miss” event for healthcare professionals and researchers who study and manage patients with inflammatory bowel diseases.

Our goal is to provide you with the information you need to optimize care of your patients and to direct your attention to advances and breakthroughs in the field.

As with last year, we will be starting the scientific agenda on Thursday afternoon. Two new workshops introduced in 2011 -- The Future of IBD and The Basics of IBD -- will again kick off the conference with engaging discussion and interaction.

The outstanding faculty is comprised of expert specialists, some new this year and some who have been with us since the first year, who will lead the sessions and interact with conference attendees.

http://www.advancesinibd.com/

13–18 December 2012 Immunological Mechanisms of Vaccination (S3)

Ottawa, Canada

Vaccines are remarkably successful in reducing morbidity and mortality from infectious diseases in both developed and developing countries. However, globally, mortality from infectious disease still exceeds 10 million deaths annually, reflecting a need for new, more effective and more deployable vaccination approaches. As many of the relatively easy vaccines have already been made, vaccinology is now tackling more difficult diseases, often caused by complex and genetically variable pathogens. A better understanding of the immunological mechanisms underpinning existing and novel vaccines is therefore required. Fortunately, research efforts to uncover new molecular and cellular techniques offer exceptional opportunities for improved vaccine design. A better understanding of the immunology of vaccination will be of value in evidence-based design of new vaccines against major global causes of mortality such as HIV, malaria and tuberculosis, and against emerging infections such as swine influenza and dengue. Advances in immunology, genomics and systems biology are beginning to offer a deeper understanding of the molecular and cellular mechanisms of host immunity, and the pivotal role played by the innate immune system in shaping the adaptive immune response. This is providing new opportunities to identify new signatures of vaccine immunogenicity and protective efficacy, which should facilitate vaccine development and guide improved vaccine design. The Keystone Symposia meeting on Immunological Mechanisms of Vaccination will bring together an interdisciplinary group of scientists in vaccinology, immunology and pathogen biology, to address recent advances in these fields and their potential for accelerating vaccine design and development.

http://www.keystonesymposia.org/12S3

24–28 December 2012 Infectious Diseases in the Adult Patient: A Primary Care Update

Hyatt Regency Sarasota, FL, USA

Following this course, the participant should be able to recognize the epidemiology and classify commonly presenting infectious diseases; identify the clinical manifestations, pathogenesis and methods of diagnosing the presenting diseases; and apply the current recommendations of pharmacologic management, referral or follow-up and prevention. This activity is expected to result in improved competence in making appropriate diagnosis and providing effective treatment and referral or follow-up care with the overall goal of improving patient outcomes.

The emphasis will be on aligning physician behavior with current guidelines and evidence-based medicine, as indicated within each topic’s specific objectives. Since Infectious Diseases is a specialty field of medicine that affects all areas of Primary Care to include: FM, IM, EM and Pediatrics, this course was designed to cover the spectrum of Infectious Diseases essential to all practicing physicians.

http://www.ams4cme.com/www/LiveSeminars/SEMLA-2720121224.aspx

14–18 January 2013 Pediatric Infectious Diseases: An Evidence-Based Approach

Hyatt Regency Sarasota, FL, USA

Following this course, the participant should be able to appraise the epidemiology and classify commonly presenting infectious diseases; differentiate among the various serious infections requiring immediate therapy; apply appropriate use of laboratory studies and determine when to refer to a specialist. This activity is expected to result in improved competence in making an appropriate diagnosis and providing effective treatment and referral or follow-up care with the overall goal of improving patient outcomes.

The emphasis will be on aligning physician behavior with current guidelines and evidence-based medicine, as indicated within each topic’s specific objectives, with a focus on diagnosis, treatment and when to refer. Since Infectious Diseases is a specialty field of medicine that affects all areas of Primary Care to include: FM, IM, EM and Pediatrics, this course was designed to cover the spectrum of Infectious Diseases essential to all practitioners at the level of a practicing physician.

http://www.ams4cme.com/www/LiveSeminars/SEMLA-2720130114.aspx

24–28 January 2013 Dermatology for Primary Care

Hyatt Regency Sarasota, FL, USA

Following this course, the participant should be able to appraise the various etiologies and pathogens for the more common lesions; distinguish the characteristics of commonly seen skin disorders and develop an appropriate differential that leads to the most probable diagnosis; apply a treatment plan and follow-up procedure that will enable the practicing physician to effectively treat many disorders. This activity is expected to result in improved competence in making appropriate diagnosis and providing effective treatment and referral or follow-up care with the overall goal of improving patient outcomes.

Since this specialty has few guidelines or evidence-based recommendations, with the exception of acne and the use of biologics, the emphasis will be based on generally accepted standards and consensus, unless otherwise indicated in the specific learning objectives, with a focus on recommendations for diagnosis, treatment and when to refer. Since Dermatologic problems often reveal systemic disorders, and the skin is the largest and most accessible “organ”, this course was designed as a review and update for practicing physicians and is applicable to most specialties.

http://www.ams4cme.com/www/LiveSeminars/SEMLA-2720130624.aspx

28 January–1 February 2013 Geriatrics: A Primary Care Approach to the Aging Population

Hyatt Regency Sarasota, FL, USA

Following this course, the participant should be able to identify the etiologies, epidemiologies and presenting clinical manifestations of the disorders described; implement a differential diagnosis and laboratory assessment plans; outline the therapeutic intervention, possible complications and preventive measures. This activity is expected to result in improved competence in making appropriate diagnosis and providing effective treatment and referral or follow-up care with the overall goal of improving patient outcomes.

When indicated in the specific objectives, emphasis will be on aligning physician behavior with current guidelines and evidence-based medicine with a focus on diagnosis, treatment and when to refer. In consideration of our aging population, a physician is expected to be competent in the fundamentals of Geriatric Medicine and rely upon a specialist only when absolutely necessary; therefore, this course was designed as a review and update for all practitioners at the level of a practicing physician.

http://www.ams4cme.com/www/LiveSeminars/SEMLA-2720130128.aspx

17–24 March 2013 Infectious Disease Review

from Ft. Lauderdale, FL, USA

Statement of Purpose: The purpose of this CME activity is to outline the management of infectious challenges in clinical practice including emerging infections and antibiotic/preventive choices.

Following attendance at this educational activity, participants should be able to:

  • Define risk factors for complicated UTIs
  • Discuss the new vaccination recommendations for 2011
  • Outline the CDC prevention guidelines for STDs
  • Discuss the increasing need for antiviral agents in the US today
  • Recognize the increasing significance of fungal infections
  • Outline three options for treating GAS carriers
  • Describe emerging resistance to problem pathogens
  • Summarize the guidelines for managing community-acquired pneumonia
  • Review the history of MRSA
  • List the characteristics of MRSA, the new C diff strain and SARS

http://www.continuingeducation.net/coursedescription.php?topic=Infectious_Disease_CME_Cruise_Caribbean_March_2013

20–23 March 2013 ASID - Australasian Society for Infectious Diseases

Canberra, Australia

The ASID Annual Scientific Meeting 2013 will explore what the future holds for infectious diseases. Specific topics will include the origins and spread of new infectious diseases, how host factors may determine outcomes from infection, what tools we can use to predict, diagnose, manage and monitor infections, as well as a range of other topics including malaria, travel-related infections, viral hepatitis, antimicrobial use and abuse, current controversies in infectious diseases and the emergence and spread of multiresistant organisms in the community. Three renowned international speakers with diverse areas of expertise have been invited to contribute to the meeting.

http://www.asid.net.au/Default2.aspx?active_page_id=337

15–19 April 2013 Emergency Medicine: Practicing According to the Evidence

Hyatt Regency Sarasota, FL, USA

Following this course, the participant should be able to appraise the epidemiology, demographics and common clinical presentations for the diseases and disorders discussed; construct an appropriate history, physical exam and laboratory evaluation to develop cost-effective and accurate diagnosis; manage as well as employ appropriate follow-up and/or specialty referral for the diseases and disorders presented. This activity is expected to result in improved competence in making appropriate diagnosis and providing effective treatment and referral or follow-up care with the overall goal of improving patient outcomes.

The emphasis will be on aligning physician behavior with current guidelines and evidence-based medicine, as indicated within each topic’s specific objectives. Emergency Medicine is a specialty that has a high rate of utilization and change in standards of care. It is often the point of entry for medical care; therefore, this course was designed to be of value to all practitioners at the level of a practicing physician in an effort to keep them abreast of current clinical practices in Emergency Medicine.

http://www.ams4cme.com/www/LiveSeminars/SEMLA-2720130415.aspx

17–21 June 2013 Family Medicine: A Review and Update of Common Clinical Problems

Hyatt Regency Sarasota, FL, USA

Following this course, the participant should be able to appraise the etiologies and recognize the clinical presentations of the commonly seen disorders presented; indicate diagnostic tests available and the suggested use for making a diagnosis; implement available treatment options and appropriate long-term care when indicated. This activity is expected to result in improved competence in making an appropriate diagnosis and providing effective treatment and referral or follow-up care with the overall goal of improving patient outcomes.

When indicated in the specific objectives, emphasis will be on aligning physician behavior with current guidelines and evidence-based medicine with a focus on diagnosis, treatment and when to refer. This course was designed to inter-relate the disorders presented in an effort to help all practitioners at the level of a practicing physician or practitioner relate their practice strategies with other providers and specialists. By doing this, it will provide them with increased competence to appropriately diagnose and refer or effectively treat their patients’ conditions to optimize their care.

http://www.ams4cme.com/www/LiveSeminars/SEMLA-2720130617.aspx

17–21 August 2013 14th European Meeting on Complement in Human Disease

Jena, Germany

The European Complement Meeting is a biannual event that is being organized by active researchers in the field of complement and being held in different Cities and countries all over Europe. Therefore it is both our honor and pleasure to invite researchers in the field of complement to Jena, to attend this 14th European Complement Meeting and to allow an active exchange on the timely topics in the field of complement and beyond. 

http://www.emchd2013.org/

5–8 September 2013 30th annual meeting of NSCMID

Aarhus, Denmark

On behalf of NSCMID, we are pleased to invite you to the 30th annual meeting of NSCMID, which will be held in Aarhus, Denmark on 5-8 September 2013.

The scientific topic is Nordic perspectives on global and emergent infections and we have created an attractive scientific programme covering relevant topics of infectious diseases and microbiology ranging from basic to clinical science.

http://www.nscmid2013.dk/index.php?id=2

5–10 September 2013 Options for the Control of Influenza

Cape Town, South Africa

Held every 3 years, Options for the Control of Influenza is the largest international scientific conference exclusively devoted to influenza.  Options VIII will showcase recent advances in the basic science and control and prevention of influenza.  Whatever your domain of expertise – virology, veterinary medicine, human medicine, public health policy, industry or journalism – Options for the Control of Influenza VIII is the premier conference bringing together experts dedicated to all aspects of influenza.  Presentation formats will include keynote addresses, invited lectures, scientific workshops, abstract presentations, satellite meetings and poster sessions.

http://optionsviii.controlinfluenza.com/

16–19 October 2013 14th European AIDS Conference

Brussels, Belgium

It is our great pleasure to invite you to Brussels to attend the 14th European AIDS Conference which is being organised under the auspices of the European AIDS Clinical Society (EACS).

We will do our best to offer an exciting scientific conference programme, composed of state-of-the-art plenary lectures as well as abstract-driven sessions presenting the latest original research in the field of HIV medicine.

As a special feature we are happy to announce that the 15th International Workshop on Co-morbidities & Adverse Drug Reactions in HIV will be affiliated with this EACS conference to allow for stimulating synergies in addressing issues concerning long-term care which are of common interest.

http://www.eacs-conference2013.com/index.php?id=40

19–22 October 2013 4th International Conference on Stem Cells and Cancer: Proliferation, Differentiation and Apoptosis

Mumbai, India

The ICSCC-2013 will cover basic and applied research on DNA replication, DNA damage and repair mechanisms, proliferation, differentiation & apoptosis of all types of stem cells as well as all types of cancer cells.

There will be discussions on various aspects of cancer research, cancer therapeutics, cancer diagnostics, anti-cancer drugs, molecular markers for cancer and stem cells, hematopoietic stem cells, embryonic stem cells, induced pluripotent stem cells, mesenchymal stem cells, cardiac and neuronal stem cells, epigenetic regulation of cancer and stem cells, cancer stem cells, stem cell therapy, clinical trials on using stem cells for treating human and animal diseases, commercialization of stem cell technologies, application of nanotechnology in stem cells and cancer research, nanomedicine for cancer and allied diseases, and other topics related to stem cells and cancer research & treatment.

http://www.icscc.in/

19–22 November 2013 8th World Congress of the World Society for Pediatric Infectious Diseases (WSPID)

Cape Town, South Africa

Join 2,000 Pediatric and Infectious Disease specialists at the 8th World Congress on Pediatric Infectious Diseases in Cape Town, South Africa, November 19-22, 2013. 

The conference provides specialists a world forum for sharing the latest knowledge and receiving updates on the treatment and prevention of pediatric infectious diseases. Organized by the World Society for Pediatric Infectious Diseases (WSPID), this biennial congress is the largest gathering of its kind.

Participants will receive a fully comprehensive scientific program featuring internationally renowned experts, sponsored and plenary symposia, free papers, poster sessions, and networking opportunities.

http://www2.kenes.com/wspid/Pages/home.aspx

12–13 December 2013 First International Symposium on Human Vector-Borne Diseases

The Big Island, Hawaii, USA

The focus for this first HVBD DART symposium is "Strategic Prevention and Treatment against Dengue". The one and half day HVBD symposium will bring together the leading and noted scientists, clinicians, researchers, public health authorities and scholars with a common interest and concern in the global situation of dengue. HVBD will infuse new research concepts and provide a platform for participants to discuss and exchange research findings, update health policies, drug discovery and development, vaccine approaches, preclinical and clinical experiences and rethink solutions in dengue prevention, treatment and control. Our goal is to introduce a new concept by inception of new information derived from distinguished delegates with different backgrounds and experiences. Our specific aim is to reduce the burden of dengue, one of the fastest growing health threats the world is facing today.

Topics:

  • Antiviral Development
  • Clinical Care and Prevention
  • Diagnosis
  • Pathophysiology
  • Vaccine Development
  • Viral Biology

http://www.informedhorizons.com/hepdart2013/HVBD/HVBD.aspx

18–22 December 2013 World Conference on Infectious Diseases

Chennai, India

WCID 2013 will cover all aspects of HIV/AIDS, TB, Malaria and other infectious diseases, as well as basic, clinical, prevention and other sciences.

http://www.wcid2013.org/

24–25 January 2014 32nd Annual UC Davis Infectious Diseases Conference

University of California, Sacramento, USA

Special features of this conference:

• Laboratory exercises designed to simulate clinical experience with the use of the clinical microbiology laboratory and the management of cases seen in practice.
• A choice of workshop sessions for practical smaller group discussions of a variety of clinical issues.

http://www.ucdmc.ucdavis.edu/cme/course_pages/INFEC/infec_pagelink.html

9–13 March 2014 9th International Symposium on Pneumococci and Pneumococcal Diseases

Hyderabad, India

The International Symposium on Pneumococci and Pneumococcal Diseases (ISPPD) is the premier global scientific symposium devoted to the exchange, advancement and dissemination of the latest discoveries on the basic science, microbiology, epidemiology, treatment and prevention of pneumococci and pneumococcal disease.

ISPPD provides an unparalleled international forum to bring together scientific, clinical and public health experts, practitioners, and students to present, discuss, challenge and learn from the latest work and advancements on pneumococcal disease.

Discover the latest achievements in the fight against the pneumococcus at ISPPD-9, hosted by INCLEN Trust, in Hyderabad, India  March 9-13, 2014.

http://isppd.kenes.com/

30 March–4 April 2014 Keystone Symposia — Novel Therapeutic Approaches to Tuberculosis

Keystone Resort, Keystone, Colorado, USA

Please refer to the website for further information.

http://www.keystonesymposia.org/index.cfm?e=web.Meeting.Program&meetingid=1290

9–11 April 2014 9th Conference Louis Pasteur Emerging Infectious Diseases

Paris, France

The conference will gather a broad range of participants: senior scientists, young investigators and students working in bacterial, parasitic and viral emerging diseases as well as dedicated sessions on vectors and on the impact of climate change in epidemics.

http://www.clp2014.org/

26–29 April 2014 German Society Of Internal Medicine 120th Congress 2014 (DGIM 2014)

Wiesbaden, Germany

Please refer to the website for further information.

http://dgim2014.de/

8–10 May 2014 ECRD 2014 : The European Conference on Rare Diseases & Orphan Products

Berlin, Germany

In the past two decades we have identified the pieces that address the needs of the rare disease community. The challenge remains to combine those pieces into a picture that drives action forward with clarity and energy into a coherent and sustainable strategic plan.

http://www.rare-diseases.eu/

8–13 June 2014 Biology of Host-Parasite Interactions — Molecular Mechanisms of Pathogenesis and Treatment of Parasitic Diseases

Newport, RI, USA

The 2014 GRC on the Biology of Host-Parasite Interactions is focused on new concepts and approaches in the study of pathogenesis associated with parasite infection. The conference will place special emphasis on human and animal diseases such as malaria, toxoplasmosis, trypanosomiasis, leishmaniasis, trichomoniasis, giardiasis, schistosomiasis and gastrointestinal nematode infection.

http://www.grc.org/programs.aspx?year=2014&program=hostpar

12–13 September 2014 7th Annual Perspectives in Rheumatic Diseases Conference

The Bellagio, Las Vegas, USA

This conference is an opportunity to catch up on new developments in this complex area of medicine. Leading experts will present clinically relevant information that you will find immediately useful in the care of your patients. Rheumatoid arthritis, psoriasis, psoriatic arthritis and the many connec­tions are covered. Sessions will also focus on osteoporosis, gout, systemic lupus erythematosus, vasculitis, systemic sclerosis and pulmonary arterial hypertension as well as the management of pain that affects patients with rheumatic diseases. Don’t miss our highly animated case sessions and discussions of co-morbidities.

http://www.globalacademycme.com/cme-topics/rheumatology/conferences/7th-annual-perspectives-in-rheumatic-diseases/conference-overview.html

22–24 September 2014 14th World Congress of the ISDE

Vancouver, Canada

The Congress promises to offer a ground breaking scientific program that covers a wide variety of topics illustrating the latest scientific and clinical developments in the field of esophagology.  The World Congress has become the premier platform not only for the presentation of new science, but also for unique networking opportunities. With more than 800 delegates from around the world attending this meeting, it provides the ideal forum to discuss the latest findings, put them into context and really understand how it can affect your practice day to day.

http://www.isde.net/2014WorldCongress/

26–28 September 2014 The Viral Hepatitis Congress 2014

Frankfurt, Germany

Please refer to the website for further information.

http://www.viral-hep.org/

6–7 October 2014 Targeting Ocular Disorders

Boston, MA, USA

This conference will address targeting of ophthalmic medications and treatments and will provide the latest results in the field, along with novel and emerging targets that hold promise in treating these quality of life threats.

Topics Include:

  • New disease pathways
  • Alternative drugs
  • Anti-inflammatories
  • Biologics
  • Bi-specific therapies
  • Novel therapeutics
  • Anti-angiogenics
  • Drugs in clinical trials

http://www.healthtech.com/Targeting-Ocular-Disorders

29–30 October 2014 Targeting Tick-Borne Diseases

Boston, MA, USA

The rapid expansion of tick-borne illness in the Americas and Europe poses great challenges for the prevention and treatment of these diseases, in both humans and animals. Though Lyme Disease continues to be the predominant disease (with estimates of as many as 300,000 new cases every year in the US), new and emerging illnesses are increasingly reported. The cost for treatment of these diseases continues to rise. As humans and animals spend more time in wooded areas, the threat becomes even more urgent. This conference will address the newest science in the pathogenesis of these diseases, along with the latest research into prevention and treatment of these crippling illnesses.

http://www.healthtech.com/Targeting-Tick-Borne-Diseases

21–23 November 2014 Coronary Artery Disease: Prevention, Detection & Treatment

Las Vegas, NV, USA

Coronary Artery Disease: Prevention, Detection, and Treatment is designed to provide practicing physicians and healthcare staff with an in-depth overview of the entire spectrum of coronary artery disease.

http://www.mayo.edu/cme/cardiovascular-diseases-2014r278

2–6 February 2015 Arrhythmias & the Heart: A Cardiovascular Update

Grand Hyatt Kauai, Hawaii

The program explores approaches to the diagnosis, management and prevention of common rhythm disorders. The diagnoses and management of atrial fibrillation are also reviewed. The program shares pearls to aid in the evaluation and assessment of patients with cardiac arrhythmias. The diagnosis and treatment of patients with congestive heart failure are integrated, as well as valvular heart.

http://www.mayo.edu/cme/cardiovascular-diseases-2015r789

18–21 February 2015 10th Congress of ECCO: Inflammatory Bowel Diseases

Barcelona, Spain

ECCO 2015 in Barcelona will again offer a broad and exciting scientific programme, covering all aspects of adult and pediatric care, of medical and surgical advances, aspects related to costs and quality of care, and the increasing knowledge about the role of the environment in IBD.

https://www.ecco-ibd.eu/ecco15

18–22 March 2015 The 12th International Conference on Alzheimer’s and Parkinson’s Diseases and related neurological disorders (AD/PD 2015)

Nice, France

The 12th International Conference on Alzheimer’s and Parkinson’s Diseases and related neurological disorders (AD/PDTM 2015) will build on the well-earned reputation of previous AD/PDTM meetings for unraveling the mechanisms and improving the treatment of Alzheimer's, Parkinson's and other related neurodegenerative diseases. Conference attendees will gain unique and powerful insights into the latest research, developments, and treatments.

http://www2.kenes.com/adpd/Pages/Home.aspx

10–11 April 2015 Drexel University-ILADS 2015 Conference Tick-borne and Other Chronic Infections, Research and Practice

Philadelphia, PA, USA

Conference Description and Goals

  • To learn a historical perspective on scientific progress in Lyme and other tick-borne disease.
  • To learn of complicating factors (specifically biofilms and polymicrobial infectious complex), and implications for chonicity, as well as the resulting diagnostic and treatment challenges.
  • To learn and review current state and options for testing, disgnosis and treatment challenges.
  • To learn current thinking on the pathophysiological mechanisms behind chronic diseases that may be relevant to Lyme and other tick-borne diseases.
  • To learn less recognized manifestations of Lyme and other tick-borne diseases, including pediatric, cognitive/psychiatric, visual, and other impacts.
  • To learn from enhanced knowledge-sharing between researchers, tick-borne disease medical experts, with front-line practitioners, and foster the development of networks for continued learning.

http://www.ilads.org/lyme_programs/drexel/ilads-drexel-lyme-conference.php

15–18 April 2015 30th International Conference of Alzheimer's Disease International

Perth, Australia

One of the world’s largest and most important conferences on Alzheimer’s disease. More than 1,500 delegates from over 60 countries are expected to attend the conference in the beautiful city of Perth, Australia.

http://www.alzint.org/2015

8–9 May 2015 International Lyme Disease Conference

Augsburg, Germany

Conference Description and Goals

  • To learn a historical perspective on scientific progress in Lyme and other tick borne diseases.
  • To learn the current state and options for testing, diagnosis and treatment protocols.
  • To learn current thinking on the pathophysiological mechanisms behind chronic diseases that may be relevant to Lyme and other tick-borne diseases.
  • To learn current thinking on the pathophysiological mechanisms behind chronic diseases that may be relevant to Lyme and other tick-borne diseases.
  • To learn about less recognized manifestations of Lyme disease, including pediatric, neurologic and neuropsychiatric presentations.
  • To learn to share knowledge between researchers, tick-borne disease medical experts, and front-line practitioners, and foster the development of networks for continued learning.

http://www.ilads.org/lyme_programs/augsburg/ilads-augsburg-lyme-conference.php

14–18 June 2015 19th International Congress of Parkinson's Disease and Movement Disorders

San Diego, CA, USA

The International Parkinson and Movement Disorder Society (MDS)
is a professional society of clinicians, scientists, and other healthcare
professionals who are interested in Parkinson’s disease, related
neurodegenerative and neurodevelopmental disorders, hyperkinetic
movement disorders, and abnormalities in muscle tone and motor control.
The spectrum of clinical disorders represented by the Society includes, but
is not limited to:
Ataxia
Chorea
Dystonia
Gait disorders
Huntington’s disease
Myoclonus and startle
Parkinson’s disease and parkinsonism
Restless legs syndrome
Sti person syndrome
Tardive dyskinesia
Tics and Tourette syndrome
Tremor and essential tremor

http://www.mdscongress2015.org/Congress-2015.htm

8–10 July 2015 Infectious Diseases World Summit

Place: Boston, MA, USA

We are pleased to invite you to attend GTCbio's Infectious Diseases World Summit, which will take place July 8-10, 2015 in Boston, MA. This event seeks to provide a forum for leaders to get the most comprehensive and wide-reaching perspective on issues, challenges, and advances in the field. The Summit is comprised of the following three conferences happening over the course of three days:

13th Vaccines Research & Development Conference (July 8-10, 2015)
4th Influenza Research & Development Conference (July 8-10, 2015)
12th Anti-Infectives Partnering & Deal-Making Conference (July 9-10, 2015)

In recent years, the field of infectious diseases has faced repeated challenges, and areas such as pricing and reimbursement, regulatory, and the discovery of novel antibiotics have yet to be overcome.

https://www.gtcbio.com/conferences/infectious-diseases-summit-overview?utm_source=newsletter1&utm_medium=idws&utm_campaign=idws15&email=molecules@mdpi.org

18–23 July 2015 Alzheimer’s Association International Conference

Washington, DC, USA

The Alzheimer’s Association International Conference® (AAIC) is the world’s largest forum for the dementia research community. International investigators, clinicians and care providers gather annually to share the latest study results, theories and discoveries to bring the world closer to breakthroughs in dementia science.

As part of the Alzheimer’s Association’s research program, AAIC serves as a catalyst for generating new knowledge about dementia and fostering a vital, collegial research community.

http://www.alz.org/aaic/

21 August 2015 Approaches to Pediatric Depression and Related Disorders 2015

Minneapolis, MI, USA

This interactive course will focus on recent developments in the diagnosis, assessment, and multimodal treatment planning for pediatric depression and related conditions such as medical comorbidities, ADHD, eating disorders, and anxiety. Course faculty will emphasize an evidence-based approach and highlight cutting edge research findings with structured psychotherapeutic techniques and psychopharmacology. Throughout the day, sessions will include self-assessment activities (with audience response system) and interactive discussions with faculty.  These sessions will facilitate challenging case discussions (generated by participants and course faculty) and treatment planning for children and adolescents with depression and comorbid disorders.

https://ce.mayo.edu/psychiatry-and-psychology/node/2814

24–26 August 2015 International Conference on Emerging Infectious Diseases

Atlanta, GA, USA

The International Conference on Emerging Infectious Diseases was first convened in 1998; ICEID 2015 marks its ninth occurence. The conference brings together public health professionals to encourage the exchange of scientific information on global emerging infectious disease issues in the United States and abroad.

http://www.iceid.org/

24–26 August 2015 International Conference on Influenza

West Drayton, UK

Influenza-2015 could be an exceptional event that brings along a novel and International mixture of Virology, Microbiology, Public health, Immunologists, Physicians, NHS and healthcare, leading universities and Companies establishments creating the conference an ideal platform to share expertise, foster collaborations across trade and world, and assess rising technologies across the world. World-renowned speakers, the most recent techniques, tactics, and the newest updates in the field of Influenza are hallmarks of this conference.

http://influenza.conferenceseries.com/

16–17 September 2015 24th Annual Symposium on Molecular Pathology: Clinical Applications of Genomic

Troy, MI, USA

The symposium provides significant opportunities for professional education, networking and resource building. You should strongly consider attending if you are involved in molecular diagnostics or are interested in learning about this fast-paced specialty of clinical laboratory medicine. We are pleased to bring you these excellent educational opportunities at modest registration fees, thanks to our commercial exhibitors.

http://cmetracker.net/BEAUMONT/

24 September 2015 Management of Hepatitis C Virus in the New Era: Small Molecules Bring Big Changes

Atlanta, GA, USA

The most important advances in HCV research and clinical care in the last year will be summarized and presented by leading experts in the field, in a 1-day CME course setting.

http://www.iasusa.org/content/fall-2015-atlanta-hep-cme-course

1–3 October 2015 8th Canadian Conference on Dementia

Ottawa, Ontario, Canada

The program boasts a plethora of new, eclectic, and interactive workshops, as well as poster presentations. As usual, the conference will conclude with clinicopathological vignettes – a true opportunity to test the knowledge that you have gained from the conference with real time cases!

http://www.canadianconferenceondementia.com/

9–11 December 2015 International Symposium in Colorectal Disease

Bangkok Hospital Phuket

This conference will comprise comprehensive scientific programs, which includes all the state-of-the-art and up-to-date technologies, knowledge, controversies, innovations and new surgical techniques in colorectal surgery as well as the updates in the relating disciplines.

http://www.phukethospital.com/Conference-Symposium/Colorectal-Disease.php

10–12 December 2015 2015 Advances in Inflammatory Bowel Diseases, Crohn’s & Colitis Foundation’s

Orlando, FL, USA

The 2015 Advances in Inflammatory Bowel Diseases, Crohn’s & Colitis Foundation’s Clinical & Research Conference is the “can’t miss” event for healthcare professionals and researchers who study and manage patients with inflammatory bowel diseases (IBD).The conference offers workshops, a four-track format designed for clinicians, researchers, allied health professionals, nurses, and pediatric gastroenterologists.

http://www.advancesinibd.com/

24–27 January 2016 Traumatic Brain Injury: Clinical, Pathological and Translational Mechanisms (J3)

Santa Fe, New Mexico, USA

This meeting focuses on: 1) What we know about mechanisms and manifestations of traumatic brain injury based on human observational studies; 2) Exploration of molecular mechanisms of injury based on animal models and translational aspects of TBI research; and 3) The development of potential diagnostics and therapeutics.

http://www.keystonesymposia.org/16J3

20–21 February 2016 International workshop on HIV & Women 2016

Boston, USA

Leading researchers, allied health professionals , caregivers, and experts in the field will share their knowledge, and provide a framework for a dialogue on the complex biologic, social, and medical intersections between HIV and women.

http://www.virology-education.com/event/upcoming/international-workshop-hiv-women-2016/

22–23 February 2016 3rd Annual International Conference on Cardiology & Cardiovascular Medicine Research (CCMR 2016)

Singapore

The Annual International Conference on Cardiology & Cardiovascular Medicine Research (CCMR) aims to be a platform for researchers, cardiologists, cardiac surgeons, and educators all over the world to present, share and exchange new medicine studies, research results, research analysis, innovations and advances in dealing with heart disorders or cardiovascular disease. - See more at: http://cardioresearch-conf.org/#sthash.KNKKsEl7.dpuf

http://cardioresearch-conf.org/

23–26 February 2016 16th Annual Minimally Invasive Surgery Symposium (MISS)

Las Vegas, Nevada, USA

MISS will offer compelling lectures, surgical video presentations, and lively discussion and debate by world-renowned experts on advanced laparoscopic techniques for managing metabolic disorders, hernia, foregut and diseases of the colon.

http://www.miss-cme.org/site/Default.aspx

1–2 April 2016 The 3rd Annual Digestive Diseases

Philadelphia, PA, USA

This knowledge-based activity will provide learners with a comprehensive overview of the state-of-the-art advances in the diagnostic, therapeutic and preventive modalities of digestive diseases based on the latest evidence, literature, and clinical research. A thorough review of the current treatment landscape is vital to both clinicians and patients who can benefit from the expansion of therapeutic options. This conference is designed for gastroenterologists, primary care physicians, advanced practice nurses, nurses, pharmacists, and physician assistants involved in the diagnosis, evaluation, management, and treatment of patients with digestive diseases.

http://www.globalacademycme.com/cme-topics/gastroenterology/conferences/3rd-annual-digestive-diseases-new-advances/conference-overview.html

21–23 April 2016 The 6th Annual Case Based Approach to Controversies in Cardiovascular Disease

Dubai

This symposium is intended for all health care professionals involved in the management of patients with cardiovascular disease, including cardiologists, cardiac surgeons, residents, fellows and nurses.

http://www.cvuae.com/welcome.html

28–30 April 2016 The 2nd World Congress on Controversies in Multiple Myeloma (COMy)

Paris, France

The 2nd COMy Congress will bring to the forefront the latest and most controversial data in the field of Multiple Myeloma, providing a unique opportunity for world class leaders in the field to debate vital and contentious issues in Myeloma.

http://www.comtecmed.com/comy/2016/Default.aspx

12–14 May 2016 HIV Update: Contemporary Issues in Management

Boston, Massachusetts, USA

The HIV Update course is a comprehensive continuing medical education program specifically designed to foster the integration of all aspects of HIV care.

http://hivupdateboston.com/

7–9 June 2016 The 2016 Alzheimer’s Disease Congress

London, UK

This international academic congress will bring to light the current research and treatments being developed for Alzheimer’s Disease.

http://lifescienceevents.com/alz2016/

22–26 June 2016 WSP 2016 — World Summit on Pediatric 2016

Porto, Portugal

Pediatric conference 2016: International interdisciplinary opinion leaders will discuss and debate on current issues in Pediatrics, including nutrition, allergy, gastroenterology, infectious disease, asthma and more.

http://www.wsp-congress.com/

8–11 August 2016 Propagation In Neurodegenerative Disease Conference 2016

Dublin, Ireland

The conference will bring together neurologists, neuropathologists and basic scientists from a wide variety of neurodegenerative diseases to discuss the implications of these mechanisms for building disease models and therapeutic strategies and so on.

http://www.zingconferences.com/conferences/propagation-in-neurodegenerative-disease-conference-2016/

12–15 September 2016 CNS Diseases World Summit

Boston, MA, USA

This meeting provides an interactive learning and relationship-building forum for all players in the CNS field. Colleagues from industry, academia, government agencies, and financing bodies will gather at the interface of research, partnerships, funding, and commercialization to find ways to move forward in a field that has been troubled with clinical failures.

https://www.gtcbio.com/conferences/cns-diseases-world-summit-overview

12–15 September 2016 Modern Drug Discovery & Development Summit (M3D)

Boston, MA, USA

The summit will bring together an exciting balance of industry and academia, so that delegates have the unique opportunity to network with colleagues from different sectors and gain fresh perspective on the various research and current developments in the field.

https://www.gtcbio.com/conferences/modern-drug-discovery-development-summit-m3d-overview

20–22 September 2016 Rare Metabolic Disorders: Detection, Research, Management and Treatment

London, UK

This conference will discuss rare metabolic disorders, their detection, current research, disease management and treatment.

http://lifescienceevents.com/metabolism2016/

26–27 September 2016 Grand Challenges in Parkinson's Disease: Genes and Pathways

Grand Rapids, Michigan

The conference will bring together hundreds of scientists, clinicians, people with Parkinson’s and caregivers to explore the latest in Parkinson’s disease research.

http://grandchallengesinpd.org/

11–12 October 2016 The 3rd Annual Microbiology & Infectious Diseases Asia Congress 2016

Singapore

Oxford Global's 3rd Annual Microbiology and Infectious Diseases Asia Congress, on 11-12 October 2016 in Singapore, showcases world-class speakers discussing novel advances in detection technologies and molecular diagnostics, clinical microbiology, microbial genomics and Infectious Disease.

http://www.microbiologyasia-congress.com/download-agenda-marketing-2/

20–22 October 2016 The 4th World Congress on Controversies, Debates and Consensus in Bone, Muscle and Joint Diseases (BMJD)

Barcelona, Spain

The 4th edition of the BMJD Congress aims to continue facilitating effective debates on clinical and therapeutic dilemmas, supported by evidence-based medicine and expert opinions resulting in agreement on timely issues. The program provides an effective forum for discussing and debating such controversies, by allowing ample time for speaker-audience discussions with world authorities on osteoarthritis, rheumatoid arthritis, inflammatory arthritis, pain, and other musculoskeletal diseases.

http://congressmed.com/bmjd/

30 October–3 November 2016 XXIV World Congress of Psychiatric Genetics 2016

Jerusalem, Israel

The WCPG is the annual meeting of the International Society for Psychiatric Genetics (ISPG), the world leading organization in genetic research in psychiatry. The conference is held alternatingly in North America and Europe, with about 700-900 participants from countries all over the world. In 2016 it will be held in Jerusalem, Israel. The fundamental aim of psychiatric genetics is to identify genes that confer susceptibility to psychiatric disorders and to elucidate the pathway from the gene to the clinical phenotype.

http://www.wcpg2016.org/

1–2 November 2016 Cancer Immunotherapy & Biofluid Biopsies 2016

Boston, USA

Cancer Immunotherapy & Biofluid Biopsies 2016 brings together the key opinion leaders in the immunotherapy and tumor immunology fields to address the most up-to-date strategies for immune therapy and means by which immunotherapies may be rationally-combined with more traditional anti-cancer therapeutics. This field is converging with biofluid biopsies/liquid biopsies and therefore this conference brings together these two disciplines as they are co-evolving.

http://selectbiosciences.com/conferences/index.aspx?conf=CIBB2016

8–9 February 2017 The 3rd International Rare Diseases Research Consortium (IRDiRC) Conference

Paris, France

The 3rd conference of the International Rare Diseases Research Consortium (IRDiRC) will take place February 8-9, 2017 in Paris, France, at the conference center of Université Pierre et Marie Curie (UPMC).
Five years have passed since the initial launch of IRDiRC and considerable advances have been made in rare diseases research. The conference presents a unique opportunity for all rare diseases stakeholders worldwide to reflect upon this progress, confront barriers, and together, form new collaborations to take on challenges posed by rare diseases, and work toward bringing diagnoses and therapies to all rare disease patients.

http://www.irdirc.org/activities/conference-2017/

10–12 February 2017 The 3rd World Congress of Clinical Lipidology

Brisbane, Australia

The 3rd World Congress on Clinical Lipidology will take place in Brisbane, Australia on 10-12 February, 2016. The 2017 Congress will cover the state of the art educational lectures in the field of clinical lipidology, focusing on practical lipid management including difficult to treat hyperlipidemias, genetic dyslipidemias, screening, dietary and nutraceutical approaches and case studies. Major emphasis will be given to new therapeutics, diagnosis and management of high risk patients.

http://clinical-lipidology.com/

6–7 March 2017 The 3rd Biologics & Biosimilars Congress

Berlin, Germany

Attracting industry, regulatory & academic experts working in all areas of protein and antibody research, the 3rd Biologics and Biosimilars Congress 2017 will feature extended panel discussions with senior executives from prominent organisations. Drawing on their experience and insights these leaders will discuss the challenges, opportunities and future direction of a range promising research fields.

http://www.global-engage.com/event/biologics/

8–10 June 2017 International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy

Washington DC, USA

This workshop will provide a platform for state-of-the-art discussions of current topics fundamental to the optimal use of antiretroviral therapy including drug-drug interactions, pharmacokinetics of investigational agents and existing drugs, pharmacodynamics, drug dosing in special populations, post-marketing surveillance project, and regulatory considerations.

http://www.virology-education.com/event/upcoming/17th-international-workshop-on-clinical-pharmacology-of-hiv-hepatitis-therapy/

Back to Top